Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05521685 · ClinicalTrials.gov registry record

Impact of EUS Guided Treatment of Gastric Varices

A clinical trial, sponsored by Indiana University.

Completed
Registry status
119
Enrollment target

NCT05521685: Completed study, sponsored by Indiana University.

NCT05521685 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 119 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05521685 has completed, sponsored by Indiana University.

COMPLETED
Registry status
119 participants
Enrollment target

Study Summary

The purpose of the study is to determine the clinical impact of cyanoacrylate tissue adhesive treatment for Gastric Varices performed by Indiana University EUS physicians.

Primary Outcome

Retrospective data review to Determine post procedure complications and adverse events at 24h, between 2 and 7 days and between 8 and 30 days after the procedure. Additionally, tracking rebleeding after first and second EUS. Moreover, looking at eradication of GV rate on second endoscopy (considered eradicated if absent or if residual varices have no or minimal flow on doppler)eradication, and need for re-intervention following cyanoacrylate tissue adhesive treatment for Gastric Varices performe

Interventions

  • PROCEDURE Endoscopic Ultrasound (EUS) administration of cyanoacrylate tissue adhesive to control bleeding gastric varices

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2022-04-19
Est. Completion 2023-05-22
Indiana University

890 total trials

What the finished NCT05521685 record still lists

NCT05521685 is an observational study that tracks outcomes without assigning an intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Endoscopic Ultrasound (EUS) administration of cyanoacrylate tissue adhesive to control bleeding gastric varices is the first listed.

NCT05521685 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05521685 about?

NCT05521685 is a clinical study titled "Impact of EUS Guided Treatment of Gastric Varices". The purpose of the study is to determine the clinical impact of cyanoacrylate tissue adhesive treatment for Gastric Varices performed by Indiana University EUS physicians.

What is the current status of trial NCT05521685?

This trial is currently completed. The enrollment target is 119 participants. The study started on 2022-04-19. Estimated completion is 2023-05-22.

What interventions are being tested in trial NCT05521685?

The interventions under investigation include: Endoscopic Ultrasound (EUS) administration of cyanoacrylate tissue adhesive to control bleeding gastric varices (PROCEDURE).

Who is sponsoring clinical trial NCT05521685?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04870762 · 119 participants · Phase 2

    Customized 3D Printed Oral Stents During Head and Neck Radiotherapy

  • NCT05559853 · 119 participants

    Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment

  • NCT06564389 · 119 participants · Phase 1

    FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

  • NCT06742801 · 119 participants · NA

    Onyx™ Liquid Embolic IDE Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05521685, the US trial registry maintained by the National Library of Medicine. NCT05521685 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.